Study Group: Clozaril Prescribers (US)
Council Members in this Study Group: 37
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Rami Kaminski, MD
Founder and Director
Institute for Integrative Psychiatry
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...
GLG NewsSM Analyses by this Study Group's Leading Experts (?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Head to Head Comparisons will Help Patients but Hurt Profits
May 27, 2008
Warning over drug trial’s effects on testing | www.ft.com
Direct comparisons between potential competing agents often do not exist Initial FDA approval is usually based on comparisons to placebo A new approval does necessarily mean that the new agent is better than existing ones, although this is implied by industry Industry bears all the costs of efficacy...
-
Eli Lilly & Company Develops Novel Antipsychotic for Treating Schizophrenia
February 27, 2008
Daring to Think Differently About Schizophrenia | www.nytimes.com
All currently marketed antipsychotic medications for treating schizophrenia rely on mechanisms of action which target dopamine and serotonin receptors. Although these medications reduce delusions and hallucinations without inducing symptoms of Parkinson's Disease...
-
February 26, 2008
Daring to Think Differently About Schizophrenia | www.nytimes.com
The clinical trial which was done has shown only comparable efficacy to available treatment for positive symptoms. It did not study efficacy for cognition or negative symptoms. It did not test efficacy in treatment resistant patients. It did not show long term efficacy. It did not showthat...
-
Not Another mGluR Drug: The Competition Is On.
January 9, 2008
Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate | www.pipelinereview.com:80
Pfizer Inc (NYSE:PFE) and Taisho Pharmaceutical Co., Ltd. (OTC:TSOPF.PK) announced the signing of a definitive agreement for worldwide collaboration to research, develop and commercialize TS-032. TS-032 is a metabotropic glutamate receptor (mGluR) agonist, a novel drug candidate for the...
-
January 8, 2008
Addex and Merck & Co., Inc. Enter License Agreement to Develop a Drug Candidate for Schizophrenia | www.pipelinereview.com:80
Addex Pharmaceuticals (Swiss:ADXN.SW) announced on January 3, 2008 an exclusive worldwide license agreement with Merck & Co., Inc. (NYSE:MRK) to develop ADX63365, a potent and selective positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5) with potential for the...
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Facility, Academic Medical Center
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Owner
- Director
- Medical Director
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Physicians who Treat Schizophrenia (US) | 371 |
| Psychiatrists (US) | 1155 |
| Psychiatrists | 1554 |
| Physicians who Treat ADHD (US) | 459 |
| Seroquel Prescribers forSchizophrenia (US) | 109 |
| Effexor XR Prescribers (US) | 148 |
| Physicians who Treat Depression (US) | 450 |